Showing 261 - 280 results of 100,934 for search '(( 5 non decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.36s Refine Results
  1. 261
  2. 262
  3. 263

    MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

    Published 2014
    “…Anti-phospho-cofilin antibody showed that MK-STYX decreased cofilin phosphorylation in non-stimulated cells relative to the MK-STYX shRNA-A. …”
  4. 264
  5. 265

    Resveratrol decreased intracellular levels of R5P. by Mohd Askandar Iqbal (324124)

    Published 2013
    “…<p>R5P is a pentose phosphate pathway intermediate, an important marker for anabolism (nucleotide biosynthesis). …”
  6. 266

    Decreased Tks5 expression results in neural crest-derived defects. by Danielle A. Murphy (212554)

    Published 2011
    “…<p>(A–B) Melanophores within the trunk region above the yolk sac extension in control MO-injected and Tks5 MO-injected embryos were qualitatively (A) and quantitatively (B) analyzed. n = 15 embryos and SEM is shown by bar. p values obtained from Student's t-test. ** denotes p<0.01. …”
  7. 267
  8. 268
  9. 269
  10. 270
  11. 271

    MAP-2 decrease follows the early PSA-NCAM reduction induced by glutamate exposure. by María Fernanda Podestá (639243)

    Published 2014
    “…MAP-2 and PSA-NCAM immunoreactive areas are expressed as mean values (±SEM) of 20–30 neurons per experimental condition. ns, non-significant; *** P<0.001 between bars, non-parametric Mann-Whitney test. …”
  12. 272
  13. 273
  14. 274
  15. 275

    Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

    Published 2014
    “…We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state.</p><p>Results</p><p>The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients.…”
  16. 276
  17. 277

    Decreased brain glucose uptake and glucose transporter expressions at early stage of female aging. by Fan Ding (302565)

    Published 2013
    “…<p>A. Representative FDG-microPET images showed an age-related decline in brain glucose uptake in nonTg brain, which was maximal between 6 and 9 months of age. …”
  18. 278
  19. 279
  20. 280

    Drp1<sup>SD</sup> overexpression in Opa1 or Marf depleted type II NBs rescues the reduced mitochondrial membrane potential. by Dnyanesh Dubal (12085942)

    Published 2022
    “…<p>A, B: Representative images showing decreased TMRM intensity in <i>opa1</i> RNAi and <i>marf</i> RNAi expressing type II NBs. …”